NASDAQ
$0.14
(0.16%)
Subscribe to get
AI Score
Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.5% in the third quarter, according to the company ...
William Blair says Applied Therapeutics (APLT)’ complete response letter from the FDA for govorestat...
Creightons (LON:CRL) First Half 2025 Results Key Financial Results Revenue: UK£27.1m (down 1.7% from...
Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) – Zacks Research reduced their Q4 2024 earnings per share estimates for Charles River Laboratories International in a ...
Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have earned a consensus rating of “Reduce” from the fifteen analysts that are covering the company, Marketbeat ...
APLT Stock Plunges on Setback Applied Therapeutics APLT announced that the FDA has issued a Complete...
On November 27, 2024, after the markets closed, the Company disclosed that the Food and Drug Administration ("FDA") issued a Complete Response Letter ("CRL") for its new drug application for ...
Vincerx Pharma (VINC) announced plans to implement cost-controls and explore strategic alternatives...
Museums of natural history have traditionally been imposing edifices with grand front steps and...
PR NewswireNEW YORK, Dec. 2, 2024 NEW YORK, Dec. 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Applied Therapeuti